Zim Laboratories Ltd (ZIMLAB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 541400 | NSE: ZIMLAB | Pharmaceuticals & Drugs | Small Cap

Zim Laboratories Share Price

70.86 -0.29 -0.41%
as on 05-Dec'25 12:10

Zim Laboratories Ltd (ZIMLAB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 541400 | NSE: ZIMLAB | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Zim Laboratories

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Semi Strong

Zim Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
42.32
Market Cap:
346.8 Cr.
52-wk low:
65
52-wk high:
127

Is Zim Laboratories Ltd an attractive stock to invest in?

1. Is Zim Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Zim Laboratories Ltd is a average quality company.

2. Is Zim Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Zim Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Zim Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Zim Laboratories Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Zim Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Zim Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10%14.2%16.1%15%4.8%8.1%12%17.5%10.1%8.4%-
Value Creation
Index
-0.30.00.20.1-0.7-0.4-0.10.3-0.3-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 268235272332274304329397365376364
Sales YoY Gr.--12.4%15.7%22%-17.3%10.7%8.5%20.4%-7.8%2.8%-
Adj EPS 1.73.72.73.20.11.72.14.32.91.81.7
YoY Gr.-118.5%-27.5%19.2%-98.1%2700%25%106.2%-33%-37.6%-
BVPS (₹) 20.524.5283131.232.234.939.947.649.949.9
Adj Net
Profit
8.117.712.915.30.38.210.221.114.18.88
Cash Flow from Ops. 22.132.136.737.121.331.94735.211.550.6-
Debt/CF from Ops. 4.42.52.22.14.22.51.11.79.32.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3.8%6.5%4.5%2.8%
Adj EPS 0.8%97.7%-4.8%-37.6%
BVPS10.4%9.9%12.7%4.8%
Share Price - 18.8% -12.8% -42.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
8.316.310.110.70.25.36.311.66.63.73.4
Op. Profit
Mgn %
11.113.512.512.97.212.111.512.91111.510.3
Net Profit
Mgn %
37.54.74.60.12.73.15.33.92.32.3
Debt to
Equity
10.70.60.50.60.50.30.30.50.50.2
Working Cap
Days
21223322621525822522218821522197
Cash Conv.
Cycle
80104896879526058959822

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 3.40%

Sales growth has been subdued in last 3 years 4.47%

Net Profit has been subdued in last 3 years -4.83%

Sales growth is not so good in last 4 quarters at -5.60%

Latest Financials - Zim Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 1.7 1.4
TTM Sales (₹ Cr.) 364 366
BVPS (₹.) 49.9 51.6
Reserves (₹ Cr.) 195 203
P/BV 1.43 1.38
PE 42.32 52.65
From the Market
52 Week Low / High (₹) 65.00 / 126.95
All Time Low / High (₹) 14.00 / 151.75
Market Cap (₹ Cr.) 347
Equity (₹ Cr.) 48.7
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Zim Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Zim Laboratories - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Zim Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales268235272332274304329397365376
Operating Expenses 239203238289255267292345325332
Manufacturing Costs14131421343038455356
Material Costs157120141160143159160199171168
Employee Cost 31334148353439465156
Other Costs 37374361424354555052
Operating Profit 29323442203738514043
Operating Profit Margin (%) 10.9%13.4%12.5%12.8%7.2%12.1%11.5%12.9%11.0%11.5%
Other Income 4632525656
Interest 1410911131186711
Depreciation 991011131515161520
Exceptional Items -50600-50000
Profit Before Tax 5182423-1919362318
Tax 0-167-3361166
Profit After Tax 51918162613251712
PAT Margin (%) 1.9%7.9%6.7%4.8%0.6%1.8%3.9%6.3%4.6%3.1%
Adjusted EPS (₹)1.13.93.83.30.41.22.75.13.42.4
Dividend Payout Ratio (%)16%2%2%5%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 98118135150151157170194232243
Share Capital 88816161616494949
Reserves 90110127134135141154145183194
Minority Interest0000000000
Debt91747062776636489193
Long Term Debt35282022272219253640
Short Term Debt56475040504517235552
Trade Payables47456672666582596372
Others Liabilities 21132240232949405757
Total Liabilities 257250294324318318337341443464

Fixed Assets

Gross Block12098113130153160174192260268
Accumulated Depreciation289192942567185100104
Net Fixed Assets 928994101111103103107160164
CWIP 34813101011264066
Investments 00058888813
Inventories38355255565475548186
Trade Receivables898888906364818810094
Cash Equivalents 6643382211
Others Assets 30284857667056555141
Total Assets 257250294324318318337341443464

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 22323737213247351151
PBT 5182423-11419362318
Adjustment 29211324252521212131
Changes in Working Capital -11-44-83-57-15-300
Tax Paid -1-2-4-1-5-1-0-7-31
Cash Flow From Investing Activity -12-7-26-23-19-6-14-35-72-41
Capex -13-9-28-18-15-6-15-36-73-37
Net Investments 112-1-10001-0
Others 000-4-3000-0-4
Cash Flow From Financing Activity -10-25-10-15-2-26-33160-9
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -4-5-354-4-33159
Interest Paid -12-10-9-10-14-10-8-6-8-12
Dividend Paid 0-1-1-1-1-0-0-0-0-0
Others 5-103-99-11-22352-6
Net Cash Flow -0-01-100-01-10

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)5.3417.2714.4511.221.163.647.9613.737.864.94
ROCE (%)9.9714.2416.0814.964.758.1212.0217.4810.138.35
Asset Turnover Ratio1.060.951.011.070.860.961.011.170.930.83
PAT to CFO Conversion(x)4.41.682.062.3110.55.333.621.40.654.25
Working Capital Days
Receivable Days112134118981027780789494
Inventory Days55555859746772596781
Payable Days129140144158176151167130130146

Zim Laboratories Ltd Stock News

Zim Laboratories Ltd FAQs

The current trading price of Zim Laboratories on 05-Dec-2025 12:10 is ₹70.86.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Zim Laboratories stood at ₹346.8.
The latest P/E ratio of Zim Laboratories as of 04-Dec-2025 is 42.32.
The latest P/B ratio of Zim Laboratories as of 04-Dec-2025 is 1.43.
The 52-week high of Zim Laboratories is ₹127.0 and the 52-week low is ₹65.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zim Laboratories is ₹363.7 ( Cr.) .

About Zim Laboratories Ltd

ZIM Laboratories Limited is a public limited company domiciled in India engaged in the manufacturing of formulation on drugs. The company also has wholly owned subsidiaries (Zim Laboratories FZE,UAE , SIA Zim Laboratories Limited, Latvia and Zim Health Technologies Limited, India) (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.

Business area of the company

The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×